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Discussion
Dr Frank W. Sellke (Boston, Mass). With the total number of
dead cells the same between groups, how do you explain the
dramatic functional difference? Second, did you evaluate the ex-
pression of inflammatory cytokines such as TNF- and IL-2 to see
whether the IL-10 transfection had an effect in this area?
Dr Fischer. Regarding the second question, we have measured
the expression of TNF-, not in this study but in the first IL-10
study that I mentioned, and TNF- and other proinflammatory
cytokines were indeed significantly lessened regarding their ex-
pression.
The first question was regarding lung function, why we see
such a difference in lung function even though we have the same
amount of cell death. I think it is not only dependent on the number
of cells that are there but also on the inflammatory response around
the cells. A cell may be in an area that is very inflamed. These
areas may not be well perfused with blood, and that might be a
reason for this huge difference in lung function.
Dr Sellke. Did you evaluate the inflammatory response histo-
logically? Was there a difference between the groups? Did you
observe more inflammation and membrane thickening, which may
impair lung function in the absence of cell death?
Dr Fischer. We saw much more hemorrhage on simple hema-
toxylin-eosin staining, and we saw much more edema. Also, wet/
dry weight ratios indicated a significant difference in the groups.
Dr G. Alexander Patterson (St. Louis, Mo). I have a follow-up
question to Dr. Sellke’s. With 30% of cells dead, it is hard to
understand that the lung is actually functioning so well. Which
cells are dead? You put the animals to death 2 hours after the
reperfusion. Do you have any data to indicate what the story would
be if you put the animals to death at 1 hour or 12 hours or 24
hours? It seems like a very brief snapshot at one time point.
Dr Fischer. Thank you very much. Your question regarding
which cells undergo cell death is a very important one. First, we
were surprised by the high number of dead cells that we discovered
in transplanted human lungs. We looked at the dead cells by
electron microscopy and found that the vast majority of dead cells
or apoptotic cells were alveolar type II cells. We saw some
interstitial cells and we also saw apoptotic neutrophils, which may
not be native cells but immigrated cells.
Regarding the second question, we have looked at later out-
come after 1 day of transplantation and reperfusion in the IL-10
study. We found, first, that gene expression continued after trans-
plant, either cold preservation or transplantation, but we have not
looked at cell death at this moment after a day. It is a very
important point, and ongoing studies now are definitely focusing
on the question; whole lung with 30% dead cells recovers from this
dramatic injury, and I think that is a very important and complex
problem by itself. We have actually several ongoing studies fo-
cusing on this recovery story.
Dr Minoru Ono (Tokyo, Japan). I am worrying about the
suppression of the inflammatory cytokine protection induced by
IL-10. It has other proinflammatory cytokine effects. Did you
check the survival model using the IL-10 while in transfection? If
you did not check the survival model, do you have any idea about
the IL-10 effect on the infection of the transplanted lung?
Dr Fischer. Is your concern that the IL-10 expression does not
reduce the release or expression of proinflammatory cytokines?
Dr Ono. No. My concern is that IL-10 induction may cause the
suppression of the inflammatory cytokine expression, including
IL-6 or TNF- or IL-2. That may impair the resistance to infection
in the survival model.
Dr Fischer. In the first IL-10 study that I mentioned we
performed several survival studies in pilot studies, and we found
that the suppression of the inflammatory response by IL-10 gene
transfection continues until day 1 after transplantation. We have
not performed survival studies beyond the first day of reperfusion
because that is probably another point that has to be focused on,
which was not the initial question of our study. That is the only
information I can provide so far to your question.
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